This website uses cookies

This websites contains videos from YouTube. This company uses cookies (third party cookies). If you do not want them to use these cookies, you can indicate so here. However, this does mean that you will not be able to watch videos on this website. We also make use of our own cookies in order to improve our website. We don’t share our data with other parties. Read more about our cookie policy

This website uses cookies to enable video and to improve the user experience. If you do not want to accept these cookies, indicate so here. Read more about our cookie policy

Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.

About the NKI

The Netherlands Cancer Institute was established on October 10, 1913. The founders, Rotgans, professor of Surgery, De Bussy, publisher, and De Vries, professor of Pathology, wanted to create a cancer institute 'where patients suffering from malignant growths could be treated adequately and where cancer and related diseases could be studied'. They bought a house on one of the canals in Amsterdam and named it the 'Antoni van Leeuwenhoek Huis', after the famous Dutch microscopist. The clinic had room for 17 patients, while the laboratory could accommodate 8 to 10 scientists.

Nowadays, The Netherlands Cancer Institute accommodates approximately 650 scientists and scientific support personnel. The Antoni van Leeuwenhoek Hospital has 185 medical specialists, 180 beds, an out-patients clinic with around 106,000 visits, 12 operating theaters and 11 irradiotion units for radiotherapy. It is the only dedicated cancer center in The Netherlands and maintains an important role as a national and international center of scientific and clinical expertise, development and training.


  • 28Mar 2017

    Online cognitive behavioral therapy is effective in improving sexual functioning of breast cancer survivors

    Breast cancer survivors who suffer from serious sexual dysfunction can benefit from internet-based cognitive behavioral therapy. This is demonstrated in a study of the research team of behavioral scientist Prof. dr. Neil Aaronson of the Netherlands Cancer Institute (NKI). The results of the study were published on February 27th in the Journal of Clinical Oncology.

    Read More
  • 14Mar 2017

    Thesis defense of Hanneke Vlaming

    On Thursday, March 16 Hanneke Vlaming will defend her PhD thesis. As a member of the group of Fred van Leeuwen she studied histones, the proteins which form the 'spools' that our DNA is wrapped around. Problems with histones can cause a range of diseases, and can also play a role in certain types of cancer.

    Read More
  • 14Mar 2017

    NKI and EU-LIFE call for an increased ERC budget

    The European Research Council (ERC) is key to excellent basic research, the cornerstone of disruptive innovation. The Netherlands Cancer Institute (NKI), together with 12 other European life-science research centers, united in the EU-LIFE alliance, urges politicians to unequivocally support the ERC by raising its budget in FP9 and endorsing its guiding principles.

    Read More
  • 27Feb 2017

    On Friday, February 24 Leila Nahidiazar defended her thesis

    Microscopic techniques are and will remain essential for studying cells. Leila Nahidiazar performed her PhD research within the group of microscope expert Kees Jalink. She studied the biological properties of cellular structures called intermediate filaments (IFs). To do this, she first needed to improve a specific type of high resolution microscopy.

    Read More

Board of Directors

Overview boards and commissions


Internal procedures

The NKI has adopted several regulations and procedures which help us organize our research along national and international standards. The most important regulations and procedures can be found here.

Read more


Technology Transfer Office

The NKI has a mission to beat cancer and performs world-beating research to increase our understanding of this disease. The knowledge that is gained in this way sometimes opens avenues for development of e.g. novel treatments or new diagnostic tests. To achieve its mission, NKI actively collaborates with private companies that have the knowledge and the means to develop products based on research results obtained at our institution.

Go to the site of the Technology Transfer Office

Scientific Annual Reports (SAR)



Group Leaders51
PhD Students187


  • Silhoutten



  • Silhoutten



  • Horloge



  • Silhoutten



  • Bed



Key Figures Research

Publications in 2014 542
Total impact of publications in 2014 3712
Avarage impact of publications 2014 6.8

Key Figures Research

Number of divisions 15
Number of Reseach groups 51
Share this page